C. Ram‐Wolff

2.3k total citations
60 papers, 694 citations indexed

About

C. Ram‐Wolff is a scholar working on Dermatology, Pathology and Forensic Medicine and Epidemiology. According to data from OpenAlex, C. Ram‐Wolff has authored 60 papers receiving a total of 694 indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Dermatology, 28 papers in Pathology and Forensic Medicine and 27 papers in Epidemiology. Recurrent topics in C. Ram‐Wolff's work include Cutaneous lymphoproliferative disorders research (54 papers), Lymphoma Diagnosis and Treatment (25 papers) and T-cell and Retrovirus Studies (21 papers). C. Ram‐Wolff is often cited by papers focused on Cutaneous lymphoproliferative disorders research (54 papers), Lymphoma Diagnosis and Treatment (25 papers) and T-cell and Retrovirus Studies (21 papers). C. Ram‐Wolff collaborates with scholars based in France, United States and Germany. C. Ram‐Wolff's co-authors include M. Bagot, Armand Bensussan, Maxime Battistella, Adèle de Masson, Anne Marie‐Cardine, Martine Bagot, Hélène Sicard, Jean‐David Bouaziz, Laurence Michel and Nicolás Ortonne and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

C. Ram‐Wolff

52 papers receiving 688 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Ram‐Wolff France 15 528 404 274 258 186 60 694
Maria Estela Martínez‐Escala United States 18 570 1.1× 370 0.9× 263 1.0× 144 0.6× 96 0.5× 34 706
Youn H. Kim United States 10 566 1.1× 366 0.9× 291 1.1× 272 1.1× 136 0.7× 12 725
Steven Horwitz United States 6 362 0.7× 252 0.6× 176 0.6× 176 0.7× 141 0.8× 7 482
Nina Booken Germany 13 333 0.6× 237 0.6× 180 0.7× 164 0.6× 104 0.6× 50 548
Michael Krathen United States 9 246 0.5× 207 0.5× 140 0.5× 160 0.6× 97 0.5× 16 472
Estela Martínez-Escala Spain 5 277 0.5× 219 0.5× 83 0.3× 189 0.7× 124 0.7× 6 447
Ariënne M. W. Van Marion Netherlands 12 277 0.5× 172 0.4× 236 0.9× 37 0.1× 114 0.6× 25 466
A. B. Fischmann United States 10 827 1.6× 608 1.5× 329 1.2× 410 1.6× 164 0.9× 11 911
Narin Apisarnthanarax United States 12 399 0.8× 235 0.6× 183 0.7× 308 1.2× 114 0.6× 17 615
Leena Karenko Finland 14 230 0.4× 169 0.4× 85 0.3× 214 0.8× 65 0.3× 20 470

Countries citing papers authored by C. Ram‐Wolff

Since Specialization
Citations

This map shows the geographic impact of C. Ram‐Wolff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Ram‐Wolff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Ram‐Wolff more than expected).

Fields of papers citing papers by C. Ram‐Wolff

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Ram‐Wolff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Ram‐Wolff. The network helps show where C. Ram‐Wolff may publish in the future.

Co-authorship network of co-authors of C. Ram‐Wolff

This figure shows the co-authorship network connecting the top 25 collaborators of C. Ram‐Wolff. A scholar is included among the top collaborators of C. Ram‐Wolff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Ram‐Wolff. C. Ram‐Wolff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Porcu, Pierluigi, C. Ram‐Wolff, Youn H. Kim, et al.. (2024). Lacutamab in patients with relapsed and/or refractory mycosis fungoides: Results from the TELLOMAK phase 2 trial.. Journal of Clinical Oncology. 42(16_suppl). 7082–7082. 4 indexed citations
2.
Ram‐Wolff, C., Adèle de Masson, Armand Bensussan, et al.. (2024). CD39 is Expressed by a Wide Range of Cutaneous T-Cell Lymphomas. SHILAP Revista de lepidopterología. 4(2). e334–e334. 2 indexed citations
3.
Battistella, Maxime, Lin‐Pierre Zhao, Gábor Dobos, et al.. (2023). CD38 Targeting in Aggressive, Treatment-Refractory Cutaneous T-Cell Lymphomas. Journal of Investigative Dermatology. 143(7). 1329–1332.e3. 6 indexed citations
4.
Louveau, Baptiste, Wendy Cuccuini, Hélène Moins‐Teisserenc, et al.. (2023). Graft-versus-lymphoma effect in skin after allogeneic hematopoietic stem cell transplantation for Sézary syndrome. European Journal of Dermatology. 33(4). 439–440.
5.
Beylot‐Barry, M., G. Quéreux, Charlée Nardin, et al.. (2023). Effectiveness of mogamulizumab in patients with Mycosis Fungoides or Sézary syndrome: A multicentre, retrospective, real‐world French study. Journal of the European Academy of Dermatology and Venereology. 37(9). 1777–1784. 13 indexed citations
6.
Ram‐Wolff, C., et al.. (2022). Validation of AAC-11-Derived Peptide Anti-Tumor Activity in a Single Graft Sézary Patient-Derived Xenograft Mouse Model. Cells. 11(19). 2933–2933. 7 indexed citations
7.
Ram‐Wolff, C., Adèle de Masson, M. Jachiet, et al.. (2022). CD30-positive anaplastic large-cell lymphoma associated with mycosis fungoides after treatment with dupilumab. European Journal of Dermatology. 32(4). 536–537. 5 indexed citations
8.
Lepelletier, C., Adèle de Masson, Arnaud Petit, et al.. (2022). Neutrophilic dermatoses. La Revue de Médecine Interne. 43(12). 727–738. 15 indexed citations
9.
André, R, C. Ram‐Wolff, & M. Bagot. (2022). Clinical characteristics of Mycosis fungoides. European Journal of Dermatology. 32(3). 421–423. 1 indexed citations
10.
Masson, Adèle de, Constance de Margerie‐Mellon, É. de Kerviler, et al.. (2021). Image‐guided lymph node core‐needle biopsy predicts survival in mycosis fungoides and Sézary syndrome*. British Journal of Dermatology. 185(2). 419–427. 6 indexed citations
11.
Kim, Rathana, Lin‐Pierre Zhao, Adèle de Masson, et al.. (2021). Clinical, pathological, and molecular features of myelodysplasia cutis. Blood. 139(8). 1251–1253. 19 indexed citations
12.
Dobos, Gábor, Laurence Michel, Maxime Battistella, et al.. (2021). Exploring the role of the skin microenvironment in cutaneous T-cell lymphoma using single cell RNA-sequencing. European Journal of Cancer. 156. S3–S4. 2 indexed citations
13.
Ram‐Wolff, C., Gábor Dobos, F. Aubin, et al.. (2021). Granulomatous slack skin: clinical retrospective study of 8 cases of the Cutaneous Lymphoma French Study Group. European Journal of Cancer. 156. S35–S36. 2 indexed citations
14.
Ram‐Wolff, C., et al.. (2021). Mogamulizumab-induced vitiligo in patients with Sézary syndrome: three cases. European Journal of Dermatology. 31(2). 213–216. 19 indexed citations
15.
Hurabielle, Charlotte, Maxime Battistella, C. Ram‐Wolff, et al.. (2018). Cutaneous presentation of adult T-cell leukemia/lymphoma (ATLL). Single-center study on 37 patients in metropolitan France between 1996 and 2016. Annales de Dermatologie et de Vénéréologie. 145(6-7). 405–412. 11 indexed citations
16.
Deschamps, Lydia, Pauline Laly, Jean‐David Bouaziz, et al.. (2017). Mycosis fongoïde chalazodermique associé à un séminome testiculaire métastatique. Annales de Dermatologie et de Vénéréologie. 144(6-7). 446–449. 1 indexed citations
17.
18.
Moins‐Teisserenc, Hélène, Emmanuel Clave, Corinne Douay, et al.. (2014). CD158k Is a Reliable Marker for Diagnosis of Sézary Syndrome and Reveals an Unprecedented Heterogeneity of Circulating Malignant Cells. Journal of Investigative Dermatology. 135(1). 247–257. 46 indexed citations
19.
Ram‐Wolff, C., et al.. (2013). Adénite sébacée neutrophilique chez une femme. Annales de Dermatologie et de Vénéréologie. 140(11). 708–712. 1 indexed citations
20.
Ortonne, Nicolás, C. Ram‐Wolff, Jérôme Giustiniani, et al.. (2010). Human and Mouse Mast Cells Express and Secrete the GPI-Anchored Isoform of CD160. Journal of Investigative Dermatology. 131(4). 916–924. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maria Estela Martínez‐Escala Breakdown of academic impact, for papers by Youn H. Kim Breakdown of academic impact, for papers by Steven Horwitz Breakdown of academic impact, for papers by Nina Booken Breakdown of academic impact, for papers by Michael Krathen Breakdown of academic impact, for papers by Estela Martínez-Escala Breakdown of academic impact, for papers by Ariënne M. W. Van Marion Breakdown of academic impact, for papers by A. B. Fischmann Breakdown of academic impact, for papers by Narin Apisarnthanarax Breakdown of academic impact, for papers by Leena Karenko
Rankless by CCL
2026